logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Toby M. Maher

imperial college london

94H-index
990Paper Count
3.4WCitation Count
Published Papers 474
Publication Date
logo
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
errERJ Open Research
IF4
err2026-02-16
err0
PREAI
errRandall, Matthew J.; Andersen, Claus A.; Brown, Kevin K.; de Bernard, Simon; Ford, Paul; Kaminski, Naftali; Kreuter, Michael; Lim, Sharlene; Maher, Toby M.; Prasad, Niyati; Prasse, Antje; Pujuguet, Philippe; Teneggi, Vincenzo; Van Den Blink, Bernt; Wain, Louise; Watkins, Timothy R.; Wuyts, Wim; Bauer, Yasmina
errShare
errSave
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
errERJ Open Research
IF4
err2026-01-01
err0
PREAI
errMaher, Toby M.; Jenkins, R. Gisli; Bonella, Francesco; Assassi, Shervin; Diefenbach, Claudia; Ittrich, Carina; Rohr, Klaus B.; Kolb, Martin
errShare
errSave
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
errBMC Pulmonary Medicine
IF2.8
err2025-12-04
err0
errOAAI
errWim A. Wuyts; Luca Richeldi; Shervin Assassi; Arata Azuma; Vincent Cottin; Anna-Maria Hoffmann-Vold; Michael Kreuter; Justin M. Oldham; Fernando J. Martinez; Claudia Valenzuela; Marlies S. Wijsenbeek; Madhu Kanakapura; Alexandra James; Gerrit Weimann; Cyril Drzewuski; Carl Coeck; Toby M. Maher
errShare
errSave
Reply: The rationale for distinguishing RB-ILD and AMP
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2025-12-01
err1
PREAI
errPiciucchi, Sara; Adegunsoye, Ayodeji; Travis, William D.; Nicholson, Andrew G.; Wells, Athol U.; Cooper, Wendy A.; Khor, Yet H.; Wijsenbeek, Marlies S.; Sharma, Amita; Hariri, Lida P.; Antoniou, Katerina; Borie, Raphael; Fabre, Aurelie; Inoue, Yoshikazu; Johannson, Kerri A.; Johkoh, Takeshi; Kawano-Dourado, Leticia; Kazerooni, Ella; Maher, Toby M.; Molyneaux, Philip L.; Protti, Raymond; Ravaglia, Claudia; Renzoni, Elisabetta A.; Saito-Koyama, Ryoko; Sverzellati, Nicola; Walsh, Simon L. F.; Wolters, Paul J.; Yang, Soo-Ryum; Ryerson, Christopher J.
errShare
errSave
Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2025-12-01
err0
PREAI
errRyerson, Christopher J.; Adegunsoye, Ayodeji; Piciucchi, Sara; Hariri, Lida P.; Khor, Yet H.; Wijsenbeek, Marlies S.; Wells, Athol U.; Sharma, Amita; Cooper, Wendy A.; Antoniou, Katerina; Borie, Raphael; Fabre, Aurelie; Inoue, Yoshikazu; Johannson, Kerri A.; Johkoh, Takeshi; Kawano-Dourado, Leticia; Kazerooni, Ella; Maher, Toby M.; Molyneaux, Philip L.; Protti, Raymond; Ravaglia, Claudia; Renzoni, Elisabetta A.; Saito-Koyama, Ryoko; Sverzellati, Nicola; Walsh, Simon L. F.; Wolters, Paul J.; Yang, Soo-Ryum; Travis, William D.; Nicholson, Andrew G.
errShare
errSave
Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2025-12-01
err33
PREAI
errRyerson, Christopher J.; Adegunsoye, Ayodeji; Piciucchi, Sara; Hariri, Lida P.; Khor, Yet H.; Wijsenbeek, Marlies S.; Wells, Athol U.; Sharma, Amita; Cooper, Wendy A.; Antoniou, Katerina; Borie, Raphael; Fabre, Aurelie; Inoue, Yoshikazu; Johannson, Kerri; Johkoh, Takeshi; Kawano-Dourado, Leticia; Kazerooni, Ella; Maher, Toby M.; Molyneaux, Philip L.; Protti, Raymond; Ravaglia, Claudia; Renzoni, Elisabetta A.; Saito-Koyama, Ryoko; Sverzellati, Nicola; Walsh, Simon L. F.; Wolters, Paul; Yang, Soo-Ryum; Travis, William; Nicholson, Andrew G.
errShare
errSave
Development and validation of a predictive 6-min walk score in patients with idiopathic pulmonary fibrosis
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2025-11-01
err0
PREAI
errNathan, Steven D.; Gao, Jie; Kim, Ho Cheol; Chandel, Abhimanyu; Chen, Henry; Lu, Xiaomin; van den Blink, Bernt; Shao, Lixin; Watkins, Timothy R.; Maher, Toby M.; Lancaster, Lisa
errShare
errSave
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
errThe Lancet Respiratory Medicine
IF32.8
err2025-09-30
err0
PREAI
errT M Maher; J G Goldin; J Hood; J Pitman; M de los Rios; B P Hobbs; A B Yu-Lin; I Buendia-Roldan; F Thien; J W Song; P C Perea; A Ramírez-Rivera; A DiFrancesco
errShare
errSave
Home is where spirometry should be: enhancing care for individuals with pulmonary fibrosis
errERJ OPEN RESEARCH
IF4
err2025-09-22
err0
PREAI
errMaher, Toby M.
errShare
errSave
Stratifying GAP Stages by MUC5B rs35705950 T-Allele Carriage Refines Survival Prediction in IPF
errLung
IF3.9
err2025-07-30
err0
PREAI
errJoanne J. van der Vis; Antje Prasse; Elisabetta A. Renzoni; Carmel J. W. Stock; Toby M. Maher; Francesco Bonella; Raphael Borie; Bruno Crestani; Wim A. Wuyts; Philip L. Molyneaux; Johannes C. Kelder; Jan C. Grutters; Coline H. M. van Moorsel
errShare
errSave
Phase 2 study design and analysis approach for BBT-877: an autotaxin inhibitor targeting idiopathic pulmonary fibrosis
errBMJ OPEN RESPIRATORY RESEARCH
IF3.4
err2025-05-22
err0
errOAAI
errMaher, Toby; Song, Jin Woo; Kramer, Mordechai Reuven; Lancaster, Lisa; Corte, Tamera J.; Yun, Jeong; Kim, KyungJin; Cho, Jimin; Sather, Luisa Fernanda; George, Peter M.; Devaraj, Anand; Jung, Jin Hyuk; Jung, Sujin
errShare
errSave
Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment
errLUNG
IF3.9
err2025-05-13
err0
errOAAI
errSurinder S. Birring; Peter V. Dicpinigaitis; Toby M. Maher; Stuart B. Mazzone; Clive P. Page; Amale Hawi; Thomas Sciascia; Alyn H. Morice
errShare
errSave
Artificial Intelligence and the Diagnosis of Interstitial Lung Disease: Are We Ready for ChatMDT?!
errRespirology
IF6.3
err2025-05-12
err0
PREAI
errToby M. Maher
errShare
errSave
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
errThe Lancet Respiratory Medicine
IF0
err2025-04-28
err0
errOAAI
errAitana Alonso-González; David Jáspez; José M Lorenzo-Salazar; Shwu-Fan Ma; Emma Strickland; Josyf Mychaleckyj; John S Kim; Yong Huang; Ayodeji Adegunsoye; Justin M Oldham; Iain Stewart; Philip L Molyneaux; Toby M Maher; Louise V Wain; Richard J Allen; R Gisli Jenkins; Jonathan A Kropski; Brian Yaspan; Timothy S Blackwell; David Zhang; Christine Kim Garcia; Fernando J Martinez; Imre Noth; Carlos Flores
errShare
errSave
Effect of Admilparant, a Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary Fibrosis
errCHEST
IF8.6
err2025-04-08
err0
PREAI
errMichael Kreuter; Toby M. Maher; Wim A. Wuyts; Claudia Valenzuela; Mark Hamblin; Sinae Kim; Aditya Patel; Brandon Elpers; Luca Richeldi
errShare
errSave
Type 1 invariant natural killer T cells drive lung fibrosis
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2024-10-30
err0
PREAI
errCalamita, Emily; Liu, Wing Han; Ogger, Patricia P.; Michalaki, Christina; Murphy, Faye; Mccarthy, Cormac; Agro, Albert; Hertz, Marc; Maher, Toby M.; Lloyd, Clare M.; Molyneaux, Philip L.; Kumar, Vipin; Byrne, Adam J.
errShare
errSave
Usual interstitial pneumonia (UIP) pattern in pulmonary sarcoidosis
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2024-10-30
err0
PREAI
errCastelli, Gioele; Srirangan, Arthihai; Sivarasan, Nishanth; Bax, Simon R.; Hewitt, Richard J.; Kokosi, Maria; George, Peter M.; Chua, Felix; Molyneaux, Philip L.; Jenkins, Richard Gisli; Renzoni, Elisabetta A.; Maher, Toby M.; Spagnolo, Paolo; Desai, Sujal; Wells, Athol U.; Kouranos, Vasileios
errShare
errSave
PM2.5 and NO2 exposure are associated with worse prognosis in IPF: Analysis of the UK PROFILE study
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2024-10-30
err0
PREAI
errTrachalaki, Athina; Goobie, Gillian; Molyneaux, Philip; Wain, Louise, V; Wells, Athol U.; Renzoni, Elisabetta; Saini, Gauri; Johnson, Simon; Maher, Toby M.; Jenkins, Gisli; Stewart, Iain
errShare
errSave
AIR - an open-label, 36-week, clinical trial of buloxibutid - investigating the disease modifying potential of a novel angiotensin II type 2 receptor agonist in IPF
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2024-10-30
err0
PREAI
errGanslandt, Cecilia; Molyneaux, Philip; Devaraj, Anand; Lindmark, Bertil; Raud, Johan; Tornling, Goran; Bengtsson, Thomas; Maher, Toby M.
errShare
errSave
Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2024-10-30
err0
PREAI
errValenzuela, Claudia; Bonella, Francesco; Moor, Catharina C.; Weimann, Gerrit; Miede, Corinna; Stowasser, Susanne; Maher, Toby M.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
F
Fernando J. Martínez
H-index: 156 · Papers: 1.3K
A
Andrew G. Nicholson
H-index: 148 · Papers: 697
A
Athol U. Wells
H-index: 141 · Papers: 1.0K
E
Eva Negri
H-index: 141 · Papers: 1.3K
A
Andrew P. Morris
H-index: 139 · Papers: 764
View more